Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sia

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 15, 2014
Neurally mediated propagating discrete clustered contractions superimposed on myogenic ripples in ex vivo segments of human ileumMerel H Kuizenga, Tiong C Sia, Kelsi N Dodds, et al.
Oncotarget|September 15, 2017
Human mesenchymal stem cells preferentially migrate toward highly oncogenic human hepatocellular carcinoma cells with activated EpCAM signalingBerwini Endaya, Shou P Guan, Jennifer P Newman, et al.
BMC Cancer|April 18, 2015
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation statusDawn Q Chong, Xin Y Toh, Ivy A W Ho, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 15, 2014
Neurally mediated propagating discrete clustered contractions superimposed on myogenic ripples in ex vivo segments of human ileumMerel H Kuizenga, Tiong C Sia, Kelsi N Dodds, et al.
Oncotarget|September 15, 2017
Human mesenchymal stem cells preferentially migrate toward highly oncogenic human hepatocellular carcinoma cells with activated EpCAM signalingBerwini Endaya, Shou P Guan, Jennifer P Newman, et al.
BMC Cancer|April 18, 2015
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation statusDawn Q Chong, Xin Y Toh, Ivy A W Ho, et al.
Pageof 6